Cerebrovascular Complications of COVID-19
- PMID: 32757751
- PMCID: PMC7467046
- DOI: 10.1161/STROKEAHA.120.031265
Cerebrovascular Complications of COVID-19
Abstract
Background and purpose: Coronavirus disease 2019 (COVID-19) evolved quickly into a global pandemic with myriad systemic complications, including stroke. We report the largest case series to date of cerebrovascular complications of COVID-19 and compare with stroke patients without infection.
Methods: Retrospective case series of COVID-19 patients with imaging-confirmed stroke, treated at 11 hospitals in New York, between March 14 and April 26, 2020. Demographic, clinical, laboratory, imaging, and outcome data were collected, and cases were compared with date-matched controls without COVID-19 from 1 year prior.
Results: Eighty-six COVID-19-positive stroke cases were identified (mean age, 67.4 years; 44.2% women). Ischemic stroke (83.7%) and nonfocal neurological presentations (67.4%) predominated, commonly involving multivascular distributions (45.8%) with associated hemorrhage (20.8%). Compared with controls (n=499), COVID-19 was associated with in-hospital stroke onset (47.7% versus 5.0%; P<0.001), mortality (29.1% versus 9.0%; P<0.001), and Black/multiracial race (58.1% versus 36.9%; P=0.001). COVID-19 was the strongest independent risk factor for in-hospital stroke (odds ratio, 20.9 [95% CI, 10.4-42.2]; P<0.001), whereas COVID-19, older age, and intracranial hemorrhage independently predicted mortality.
Conclusions: COVID-19 is an independent risk factor for stroke in hospitalized patients and mortality, and stroke presentations are frequently atypical.
Keywords: cerebrovascular disorders; demography; odds ratio; pandemics; risk factors.
Conflict of interest statement
None.
Figures
References
-
- COVID-19 dashboard by the Center for Systems Science and Engineering at Johns Hopkins University. https://gisanddata.maps.arcgis.com/apps/opsdashboard/index.html - /bda75.... Accessed July 25, 2020. - PMC - PubMed
-
- Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW; Northwell COVID-19 Research Team Presenting characteristics, comorbidities and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA 20203232052–2059doi: 10.1001/jama.2020.6775 - PMC - PubMed
-
- Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, Wu Y, Zhang L, Yu Z, Fang M, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med 20208475–481doi: 10.1016/S2213-2600(20)30079-5 - PMC - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous
